-+ 0.00%
-+ 0.00%
-+ 0.00%

Ixico Wins New Contract, Extension Totaling GBP1.5 Million

MT Newswires·10/22/2026 05:06:00
Listen to the news
05:06 AM EDT, 10/22/2026 (MT Newswires) -- Ixico (IXI.L) secured a new contract and an extension worth a combined 1.5 million pounds sterling for neuroimaging in Alzheimer's disease diagnostics. The British neuroscience imaging and biomarker analytics company will manage and analyze neuroimaging for a Phase 2b clinical trial in Alzheimer's for an undisclosed biotechnology company over three years, according to a Thursday release. Ixico also secured a one-year extension to a contract with an international life sciences and diagnostics client for the use of its IXI neuroimaging platform to support validation and regulatory approval of a blood-based biomarker to diagnose Alzheimer's.